1. Home
  2. VRAX vs MBOT Comparison

VRAX vs MBOT Comparison

Compare VRAX & MBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRAX
  • MBOT
  • Stock Information
  • Founded
  • VRAX 2013
  • MBOT 2010
  • Country
  • VRAX United Kingdom
  • MBOT United States
  • Employees
  • VRAX N/A
  • MBOT N/A
  • Industry
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • MBOT Medical/Dental Instruments
  • Sector
  • VRAX Health Care
  • MBOT Health Care
  • Exchange
  • VRAX Nasdaq
  • MBOT Nasdaq
  • Market Cap
  • VRAX 4.7M
  • MBOT 99.3M
  • IPO Year
  • VRAX 2022
  • MBOT N/A
  • Fundamental
  • Price
  • VRAX $0.85
  • MBOT $2.63
  • Analyst Decision
  • VRAX Strong Buy
  • MBOT Strong Buy
  • Analyst Count
  • VRAX 1
  • MBOT 1
  • Target Price
  • VRAX $3.00
  • MBOT $9.00
  • AVG Volume (30 Days)
  • VRAX 37.0K
  • MBOT 1.3M
  • Earning Date
  • VRAX 02-05-2025
  • MBOT 08-13-2025
  • Dividend Yield
  • VRAX N/A
  • MBOT N/A
  • EPS Growth
  • VRAX N/A
  • MBOT N/A
  • EPS
  • VRAX N/A
  • MBOT N/A
  • Revenue
  • VRAX $6,331.00
  • MBOT N/A
  • Revenue This Year
  • VRAX $5,169.18
  • MBOT N/A
  • Revenue Next Year
  • VRAX $66.97
  • MBOT N/A
  • P/E Ratio
  • VRAX N/A
  • MBOT N/A
  • Revenue Growth
  • VRAX 7.03
  • MBOT N/A
  • 52 Week Low
  • VRAX $0.74
  • MBOT $0.82
  • 52 Week High
  • VRAX $9.00
  • MBOT $3.38
  • Technical
  • Relative Strength Index (RSI)
  • VRAX 45.05
  • MBOT 55.29
  • Support Level
  • VRAX $0.74
  • MBOT $2.43
  • Resistance Level
  • VRAX $0.88
  • MBOT $2.60
  • Average True Range (ATR)
  • VRAX 0.07
  • MBOT 0.12
  • MACD
  • VRAX 0.01
  • MBOT 0.01
  • Stochastic Oscillator
  • VRAX 50.23
  • MBOT 100.00

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

Share on Social Networks: